The following investigations were performed during the in - life phase : mortality , clinical signs , body weight ( daily ) , food consumption ( weekly ) , clinical biochemistry ( days 3 and 28 ) and toxicokinetic determinations ( 0.5 , 1 , 3 , 7 and 24 hours after 28th administration ) .
The following investigations were performed during the in - life phase : mortality , clinical signs , body weight ( daily ) , food consumption ( weekly ) , clinical biochemistry ( days 3 and 28 ) and toxicokinetic determinations ( 0.5 , 1 , 3 , 7 and 24 hours after 28th administration ) .
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O